Inventor · disambiguated record
Sandip P. Mehta
Also filed as: MEHTA SANDIP · MEHTA SANDIP P · MEHTA SANDIP PARESHBHAI
35 granted patents·19 pending applications·28 citations·filing 2015–2025
96Inventor score
Files withLIQMEDS WORLDWIDE LTD25FTF PHARMA PRIVATE LTD14AZURITY PHARMACEUTICALS INC6ONCOSOL LTD4KASHIV BIOSCIENCES LLC2
Top patents by PatentIndex Score
54 records- 0195US12016857B2Stable liquid vigabatrin pharmaceutical composition for oral dosageFTF PHARMA PRIVATE LTD·Filed 2023·Granted Jun 25, 2024·3 cites·12 claims
- 0295US11931455B2Pharmaceutical suspension for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 19, 2024·2 cites·2 claims
- 0395US11337979B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2021·Granted May 24, 2022·3 cites·30 claims
- 0491US11464778B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2018·Granted Oct 11, 2022·2 cites·40 claims
- 0590US12226526B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Feb 18, 2025·0 cites·30 claims
- 0690US12194143B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 14, 2025·0 cites·30 claims
- 0790US12186322B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 7, 2025·0 cites·30 claims
- 0890US12186321B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jan 7, 2025·0 cites·30 claims
- 0990US11738020B2Stable liquid vigabatrin pharmaceutical composition for oral dosageFTF PHARMA PRIVATE LTD·Filed 2019·Granted Aug 29, 2023·3 cites·11 claims
- 1090US11478456B2Oral pharmaceutical composition comprising Zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2022·Granted Oct 25, 2022·1 cites·20 claims
- 1189US12370136B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jul 29, 2025·0 cites·13 claims
- 1289US12097284B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Sep 24, 2024·0 cites·1 claims
- 1389US12097285B2Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Sep 24, 2024·0 cites·2 claims
- 1489US2024245688A1Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2024·Application pending·0 cites
- 1588US12491179B2Oral pharmaceutical composition comprising zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2024·Granted Dec 9, 2025·0 cites·4 claims
- 1688US12005062B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Jun 11, 2024·0 cites·30 claims
- 1787US12168069B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Dec 17, 2024·0 cites·13 claims
- 1887US11975006B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2023·Granted May 7, 2024·0 cites·28 claims
- 1986US12343338B2Ramipril solution for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2024·Granted Jul 1, 2025·0 cites·16 claims
- 2086US11918684B2Pharmaceutical composition of oral suspension of immunosuppressive agentsLIQMEDS WORLDWIDE LTD·Filed 2018·Granted Mar 5, 2024·2 cites·3 claims
- 2185US11529333B2Oral pharmaceutical composition comprising zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2019·Granted Dec 20, 2022·1 cites·13 claims
- 2284US11925704B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 12, 2024·0 cites·13 claims
- 2384US11759468B2Liquid oral formulations for sildenafilLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Sep 19, 2023·0 cites·30 claims
- 2484US11147810B2Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agentsFTF PHARMA PRIVATE LTD·Filed 2018·Granted Oct 19, 2021·6 cites·4 claims
- 2583US11666576B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2022·Granted Jun 6, 2023·0 cites·30 claims
- 2683US10314880B2Composition comprising bortezomibFTF PHARMA PRIVATE LTD·Filed 2016·Granted Jun 11, 2019·5 cites·7 claims
- 2781US2023218586A1Oral pharmaceutical composition comprising zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2881US2023241036A1Oral pharmaceutical composition comprising zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2980US11654106B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2022·Granted May 23, 2023·0 cites·11 claims
- 3080US2023046943A1Oral pharmaceutical composition comprising zonisamide and process of preparation thereofAZURITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3179US11382917B2Liquid oral formulations for tadalafilLIQMEDS WORLDWIDE LTD·Filed 2021·Granted Jul 12, 2022·0 cites·30 claims
- 3277US12251361B2Solutions for oral dosageLIQMEDS WORLDWIDE LTD·Filed 2023·Granted Mar 18, 2025·0 cites·7 claims
- 3375US2021308044A1Pharmaceutical suspension for oral dosageFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 3474US2025144013A1Mycophenolate Oral SuspensionLIQMEDS WORLDWIDE LTD·Filed 2025·Application pending·0 cites
- 3574US2024165024A1Mycophenolate oral suspensionLIQMEDS WORLDWIDE LTD·Filed 2024·Application pending·0 cites
- 3673US12440534B2Stable ready to dilute composition of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2024·Granted Oct 14, 2025·0 cites·16 claims
- 3771US2024374516A1Ready to use oral pharmaceutical suspension of dasatinibONCOSOL LTD·Filed 2024·Application pending·0 cites
- 3869US2024216373A1Liquid dosage forms of imatinibSHORLA PHARMA LTD·Filed 2024·Application pending·0 cites
- 3968US11369567B2Aqueous suspension suitable for oral administrationLIQMEDS WORLDWIDE LTD·Filed 2017·Granted Jun 28, 2022·0 cites·5 claims
- 4066US12303504B2Non-aqueous chemotherapeutic suspensions for oral dosageONCOSOL LTD·Filed 2019·Granted May 20, 2025·0 cites·14 claims
- 4166US12083222B2Chemotherapeutic pharmaceutical suspension for oral dosageONCOSOL LTD·Filed 2019·Granted Sep 10, 2024·0 cites·20 claims
- 4265US11147817B2Pharmaceutical composition of pemetrexedFTF PHARMA PRIVATE LTD·Filed 2020·Granted Oct 19, 2021·0 cites·18 claims
- 4362US11957681B2Liquid dosage forms of ImatinibSHORLA PHARMA LTD·Filed 2018·Granted Apr 16, 2024·0 cites·1 claims
- 4457US2022347122A1Solutions for oral dosageFTF PHARMA PRIVATE LTD·Filed 2020·Application pending·0 cites
- 4553US2020188478A1Pre-mixed, ready to use vancomycin compositionsFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4653US2025170123A1Non-aqueous oral suspension of temozolomideONCOSOL LTD·Filed 2025·Application pending·0 cites
- 4752US2019290718A1Composition comprising bortezomibFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4850US2021030671A1Liquid dosage forms of cinacalcet or salt thereofFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 4950US2021213024A1Liquid compositions of aprepitantFTF PHARMA PRIVATE LTD·Filed 2019·Application pending·0 cites
- 5049US2017340639A1Pharmaceutical composition of pemetrexedFTF PHARMA PRIVATE LTD·Filed 2015·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →